Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your favorites.
This session is in your favorites. Click again to remove it.
Presentation Icons
Live Stream Sessions
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Gabarin, Nadia
Canadian Blood Services
OA3-AM24-MN-08 - Plasma Transfusion Practice: A Multi-Center Audit of 10,008 Admissions with Plasma Transfusionat 23 Hospitals
Location: 372
Nadia Gabarin
Favorite
Galipeau, Jacques
University of Wisconsin in Madison
AM24-SN-01-L - The Future of Cellular Therapy Using Mesenchymal Stromal Cells and Dendritic Cells
Location: 320
Jacques Galipeau
Favorite
Gammon, Richard
Carter BloodCare
AM24-MN-08-L - Oral Abstract - Patient Blood Management
Location: 372
Richard Gammon
Favorite
AM24-ST-11-L - Coverage and Reimbursement Policy 101 for Transfusion Medicine and Cellular Therapies
Location: 372
Richard Gammon
Favorite
Ghevaert, Cedric
University of Cambridge / NHS Blood and Transplant
AM24-MN-32-L - Lyophilized, Stem-cell Derived, and Synthetic Platelet Products are Closer Than You May Think.
Location: 362
Cedric Ghevaert
Favorite
Gibb, David
Cedars-Sinai Medical Center
PL3-SN-27 - Antioxidant Responses Regulate RBC Alloimmunization
David Gibb
Favorite
Goel, Ruchika
Vitalant and Johns Hopkins University
AM24-MN-33-L - Resilience Explored: Navigating Post-Pandemic Blood Products Utilization Trends and Supply Challenges in North America
Location: 372
Ruchika Goel
Favorite
AM24-SN-17-L - Sickle Cell Disease: Inching towards Transfusion Independence. Exploring the Journey from Chronic Transfusions to the Novel Biotherapeutics
Location: Grand Ballroom B
Ruchika Goel
Favorite
OA2-AM24-MN-08 - Machine Learning Versus Traditional Regression Analytics to Study the Association between Peri-Operative Red Blood Cell Transfusions and Venous Thromboembolism
Location: 372
Ruchika Goel
Favorite
OA1-AM24-MN-39 - Healthcare Burden And Factors Associated With Re-admission Among Patients with Sickle Cell Disease in the United States: Insights From a Nationally Representative Database
Location: 342
Ruchika Goel
Favorite
OA1-AM24-TU-07 - Gender-Specific Individual Donor Assessment (IDA) based Deferral Rates as Compared to MSM Based Deferral in a Large US Blood Collection Establishment
Location: 362
Ruchika Goel
Favorite
Goldman, Mindy
Canadian Blood Services
AM24-SN-21-L - Beyond Gender-Based Sexual Activity Blood Safety Rules - Outcomes and Next Steps
Location: 332
Mindy Goldman
Favorite
OA2-AM24-ST-27 - Deferrals for Pre-Exposure Prophylaxis (PrEP) for HIV Before and After the Switch to Sexual Risk Behaviour Screening
Location: 362
Mindy Goldman
Favorite
OA2-AM24-TU-07 - Implementation of Sexual Risk Behaviour Donor Screening
Location: 362
Mindy Goldman
Favorite
Gonzalez, Judith
Hoxworth Blood Center
Science & Innovation Theater presented by Terumo
Location: Exhibit Hall A3/B3
Judith Gonzalez
Favorite
Gonzalez, Leticia
Science & Innovation Theater presented by Sanofi
Location: Exhibit Hall A3/B3
Leticia Gonzalez
Favorite
Grable, Martin
OneBlood
AM24-ST-29-L - Case Studies: Cyber Threats in Healthcare
Location: Grand Ballroom B
Martin Grable
Favorite
Gravemann, Ute
German Red Cross Blood Service NSTOB
OA2-AM24-ST-13 - In Vitro Quality of RBCs in PAGGS-M Prepared in Non-DEHP Bag Systems: Influence of Weekly Mixing
Location: 342
Ute Gravemann
Favorite
Guleria, Indira
BIDMC and Harvard Medical School
AM24-TU-01-L - Beyond CAR T: Non-Conventional Applications of CAR Technology in Biotherapies
Location: 320
Indira Guleria
Favorite
Gunawardena, Naomi
Children's Hospital of Philadelphia
OA2-AM24-MN-39 - Complication Rates in Patients with Sickle Cell Disease on Hydroxyurea Managed With or Without Pre-Anesthesia Transfusion
Location: 342
Naomi Gunawardena
Favorite
Gustafson, Michael
Mayo Clinic in Arizona
AM24-SN-01-L - The Future of Cellular Therapy Using Mesenchymal Stromal Cells and Dendritic Cells
Location: 320
Michael Gustafson
Favorite
